NEUROPORTER
Live / Registered — Registered and renewed (as of 11 Jun 2024)
What this means for you
Registered since 02 Dec 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Dec 2023).
Record
- Serial number
- 76407987
- Registration number
- 2789587
- Mark type
- Word mark
- Filed
- 15 May 2002
- Published for opposition
- 26 Nov 2002
- Registered
- 02 Dec 2003
- Next maintenance due
- 02 Dec 2023
- Attorney of record
- Maria V. Stout
Goods and services
- Class 001 — Chemicals: REAGENTS FOR SCIENTIFIC OR MEDICAL RESEARCH
Owner
- AMS BIOTECHNOLOGY (EUROPE) LTD, ABINGDON, GB
- Gene Therapy Systems, Inc., San Diego, CA, US
- Gene Therapy Systems, Inc., San Diego, CA, US
- Gene Therapy Systems, Inc., San Diego, CA, US
Prosecution history
- 11 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 11 Jun 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 11 Jun 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 11 Jun 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Mar 2024 — TEAS SECTION 8 & 9 RECEIVED
- 26 Jul 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Dec 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 07 Aug 2017 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Aug 2017 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Dec 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Dec 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Dec 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 26 Nov 2013 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 12 Dec 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Nov 2013 — TEAS SECTION 8 & 9 RECEIVED